Natera Inc (NTRA):企業の製品パイプライン分析

◆英語タイトル:Natera Inc (NTRA) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME178267PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers Panorama, a non-invasive prenatal screening test that analyzes baby’s DNA through a simple blood draw from the mother’s arm; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening test; and Spectrum pre-implantation genetic screening and diagnosis to analyze inherited genetic conditions. Natera’s Signatera (RUO) is a ctDNA assay used for tumor treatment, monitoring and minimal residual disease (MRD) assessment. It also offers constellation, a cloud-based software product that allows laboratory customers access company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Natera Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Natera Inc Company Overview
Natera Inc Company Snapshot
Natera Inc Pipeline Products and Ongoing Clinical Trials Overview
Natera Inc – Pipeline Analysis Overview
Natera Inc – Key Facts
Natera Inc – Major Products and Services
Natera Inc Pipeline Products by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc Pipeline Products Overview
Panorama Non-Invasive Prenatal Expanded Test
Panorama Non-Invasive Prenatal Expanded Test Product Overview
Panorama Non-Invasive Prenatal Expanded Test Clinical Trial
Prospera Kidney Transplant Rejection Test
Prospera Kidney Transplant Rejection Test Product Overview
Prospera Kidney Transplant Rejection Test Clinical Trial
Reproductive Health Test
Reproductive Health Test Product Overview
Signatera – Bladder Cancer
Signatera – Bladder Cancer Product Overview
Signatera – Breast Cancer
Signatera – Breast Cancer Product Overview
Signatera – Breast Cancer Clinical Trial
Signatera – GI Tumors
Signatera – GI Tumors Product Overview
Signatera – Lung Cancer (Opdivo)
Signatera – Lung Cancer (Opdivo) Product Overview
Signatera – Lung Cancer (Opdivo) Clinical Trial
Signatera – Metastatic Non-Small Cell Lung Cancer
Signatera – Metastatic Non-Small Cell Lung Cancer Product Overview
Signatera – Multiple Myeloma
Signatera – Multiple Myeloma Product Overview
Signatera – Multiple Myeloma Clinical Trial
Signatera – Non-Hodgkin’s Lymphoma
Signatera – Non-Hodgkin’s Lymphoma Product Overview
Signatera – Pan-Cancer
Signatera – Pan-Cancer Product Overview
Signatera – Prostate Cancer
Signatera – Prostate Cancer Product Overview
Natera Inc – Key Competitors
Natera Inc – Key Employees
Natera Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Natera Inc, Recent Developments
Jan 20, 2021: Natera files patent infringement suit against Inivata
Dec 18, 2020: U.S. patent office upholds validity of Natera’s early priority date ’592 cfDNA patent
Oct 05, 2020: Court rejects ArcherDX’s motion to dismiss Natera’s patent infringement case
Aug 07, 2020: Natera files additional suit against ArcherDX
Jun 17, 2020: Anju Software welcomes Natera to its PUBSTRAT partner community
May 18, 2020: Natera and Illumina settle patent dispute
Apr 15, 2020: Natera asserts three new oncology patents against ArcherDX
Mar 04, 2020: Natera to showcase leadership in cell-free DNA at CEoT conference
Mar 03, 2020: Natera receives favorable medicare reimbursement pricing for Prospera
Feb 26, 2020: Natera reports fourth quarter and year 2019 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Natera Inc Pipeline Products and Ongoing Clinical Trials Overview
Natera Inc Pipeline Products by Equipment Type
Natera Inc Pipeline Products by Indication
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc, Key Facts
Natera Inc, Major Products and Services
Natera Inc Number of Pipeline Products by Development Stage
Natera Inc Pipeline Products Summary by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc Ongoing Clinical Trials Summary
Panorama Non-Invasive Prenatal Expanded Test - Product Status
Panorama Non-Invasive Prenatal Expanded Test - Product Description
Panorama Non-Invasive Prenatal Expanded Test - SNP-based Microdeletion and Aneuploidy Registry
Prospera Kidney Transplant Rejection Test - Product Status
Prospera Kidney Transplant Rejection Test - Product Description
Prospera Kidney Transplant Rejection Test - INTERCOMEX DD-cfDNA-HLA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology
Prospera Kidney Transplant Rejection Test - PEDAL Study: Prospera Test Enhancement by Detecting Background Cell-free DNA Levels
Prospera Kidney Transplant Rejection Test - Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
Prospera Kidney Transplant Rejection Test - The Prospera Kidney Transplant Active Rejection Assessment Registry: ProActive
Reproductive Health Test - Product Status
Reproductive Health Test - Product Description
Signatera - Bladder Cancer - Product Status
Signatera - Bladder Cancer - Product Description
Signatera - Breast Cancer - Product Status
Signatera - Breast Cancer - Product Description
Signatera - Breast Cancer - A Clinical Study To Evaluate the Molecular Response and Minimal Residual Disease (MRD) in Women with Early Stage Breast Cancer
Signatera - Breast Cancer - Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation
Signatera - GI Tumors - Product Status
Signatera - GI Tumors - Product Description
Signatera - Lung Cancer (Opdivo) - Product Status
Signatera - Lung Cancer (Opdivo) - Product Description
Signatera - Lung Cancer (Opdivo) - Signatera ctDNA Assay as a Potential Biomarker for Opdivo (Nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clinical Trial
Signatera - Metastatic Non-Small Cell Lung Cancer - Product Status
Signatera - Metastatic Non-Small Cell Lung Cancer - Product Description
Signatera - Multiple Myeloma - Product Status
Signatera - Multiple Myeloma - Product Description
Signatera - Multiple Myeloma - Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation
Signatera - Non-Hodgkin's Lymphoma - Product Status
Signatera - Non-Hodgkin's Lymphoma - Product Description
Signatera - Pan-Cancer - Product Status
Signatera - Pan-Cancer - Product Description
Signatera - Prostate Cancer - Product Status
Signatera - Prostate Cancer - Product Description
Natera Inc, Key Employees
Natera Inc, Subsidiaries
Glossary

★海外企業調査レポート[Natera Inc (NTRA):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evoke Pharma Inc (EVOK):企業の財務・戦略的SWOT分析
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases (GI). The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. Evoke Pharma also offe …
  • Streamline Health Solutions Inc (STRM):医療機器:M&Aディール及び事業提携情報
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • ZincX Resources Corp:企業の戦略・SWOT・財務分析
    ZincX Resources Corp - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Murata Manufacturing Co., Ltd.:企業の戦略・SWOT・財務分析
    Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Phenex Pharmaceuticals AG (Phenex Pharmaceuticals) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services such as NR selectivity screening, contract screening services, and SNuRM profiling to pharmaceutical …
  • UCB SA (UCB):医療機器:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Quilvest Wealth Management:企業の戦略・SWOT・財務分析
    Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Biomatrica Inc-医療機器分野:企業M&A・提携分析
    Summary Biomatrica Inc (Biomatrica) is a biological stabilization products developer that offers healthcare technology products. The company offers assay design and use; omics sample collection, and transport and storage chemistry products. Its transport and storage chemistry products comprise custo …
  • DEPObank – Banca Depositaria Italiana S.p.A:企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana S.p.A - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Crane Co.:企業の戦略・SWOT・財務情報
    Crane Co. - Strategy, SWOT and Corporate Finance Report Summary Crane Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Mytilineos Holdings Sa:企業の戦略・SWOT・財務分析
    Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report Summary Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Vigo Coal Company Incorporated:企業の戦略・SWOT・財務情報
    Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vigo Coal Company Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務分析
    TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ArQule Inc (ARQL)-製薬・医療分野:企業M&A・提携分析
    Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including …
  • Adams Resources & Energy, Inc.:企業の戦略・SWOT・財務分析
    Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆